Italy stands as a beacon of the global healthcare and nutraceutical market. With one of the world’s oldest populations and a cultural emphasis on "La Dolce Vita" which increasingly includes wellness and preventive care, the demand for high-quality Health Care Products is soaring. As a leading Health Care Product Supplier & Factory for Italy, we recognize the nuanced requirements of the Italian "Farmacia" and "Parafarmacia" sectors, which demand not only raw efficacy but also rigorous safety standards and clean-label certifications.
Italy is currently Europe's largest market for food supplements, with a market value exceeding €4 billion. The industrial clusters around Milan, Bologna, and Rome are transforming into "Green Pharma" hubs. Italian consumers are increasingly shifting from synthetic drugs to botanical extracts and bio-active compounds. Our factory supports this transition by providing GMP-certified raw materials like Coenzyme Q10 and Argan Stem Cells, which align with the Italian Ministry of Health (Ministero della Salute) guidelines.
Globally, the industry is witnessing a "Longevity Revolution." Ingredients that support cellular health, such as Nicotinamide and Liposomal Ca-AKG, are no longer niche; they are foundational components of modern health regimens. The integration of AI in peptide discovery—like the development of BPC-157 and GHK-Cu—is accelerating the timeline from factory to pharmacy shelf. We provide "Information Gain" to our Italian partners by not just supplying ingredients, but by offering technical dossiers that facilitate rapid product registration.
Established in 2018, Shaanxi Bieyouth Biotech Co., Ltd. has emerged as a gold-standard supplier integrating R&D, production, and global export. Our facility operates under GMP certification, housing two standardized workshops equipped with cutting-edge supercritical extraction technology. We specialize in the synergy between traditional plant extracts and modern bio-pharmaceutical raw materials.
By 2026, we anticipate a massive shift toward Epigenetic Healthcare. Our R&D is currently focused on:
Enhancing the bioavailability of botanical extracts like Glabridin and Tetrandrine for superior absorption.
Advanced liquid and solid-phase synthesis for GHK-Cu and TB500 (Thymosin β4).
Utilizing Argania Spinosa stem cells to revolutionize anti-aging dermatology.
Solvent-free extraction processes that meet the "Eco-Bio" demands of Italian consumers.
Showcased innovative bio-actives at the Shanghai International Cosmetics Exhibition.
Obtained official FDA certification, expanding global trust and authority.
Launched the Institute of Biology for dedicated cosmetic raw material research.
Shaanxi Bieyouth Biotech founded with a vision for green, natural health solutions.
Bieyouth
